Internal Medicine, Hematology & Oncology · Greensboro, NC
NPI
1154372738
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
501 N Elam Ave
Greensboro, NC, 27403
Phone (336) 832-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
986 services
Medicare patients, 2024
223
Average age 74
Drug cost, 2024
$4.9M
3,228 prescriptions
Company payments, 2025
$2,260
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter R Ennever was code 99214 (office e&m - established), 392 times for 136 patients. In total Peter R Ennever billed 986 services in 15 codes, and Medicare paid $64K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 392 | 136 | $67.40 | $26K |
| 99213 Office E&M - Established | Office | 262 | 135 | $41.88 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 118 | 27 | $58.70 | $6,927 |
| 99215 Office E&M - Established | Office | 74 | 42 | $98.41 | $7,282 |
| 99233 Hospital E&M - Subsequent | Facility | 53 | 15 | $87.72 | $4,649 |
| 99222 Hospital E&M - Initial | Facility | 33 | 24 | $91.44 | $3,017 |
| 99204 Office E&M - New | Office | 16 | 16 | $68.32 | $1,093 |
| 99223 Hospital E&M - Initial | Facility | 12 | 11 | $118.43 | $1,421 |
| 99205 Office E&M - New | Office | 11 | 11 | $122.54 | $1,348 |
By year: 2022 $73K for 1,095 services; 2023 $72K for 1,056 services; 2024 $64K for 986 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter R Ennever prescribed most often to Medicare patients was Xarelto (Rivaroxaban), with 195 prescriptions and refills. In total Peter R Ennever wrote 3,228 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xarelto Rivaroxaban | 195 | 294 | 33 | $158K |
| Eliquis Apixaban | 149 | 216 | 26 | $126K |
| Famciclovir Generic | 116 | 170 | 27 | $5,370 |
| Ondansetron Hcl Generic | 103 | 103 | 57 | $734 |
| Levothyroxine Sodium Generic | 95 | 151 | 22 | $416 |
| Oxycodone Hcl Generic | 89 | 89 | 13 | $1,906 |
| Prochlorperazine Maleate Generic | 88 | 88 | 53 | $1,002 |
| Hydroxyurea Generic | 81 | 162 | 19 | $2,508 |
| Gabapentin Generic | 76 | 108 | 17 | $1,070 |
| Dexamethasone Generic | 73 | 88 | 43 | $1,509 |
| Letrozole Generic | 73 | 183 | 22 | $1,189 |
| Venclexta Venetoclax | 68 | 68 | Under 11 | $278K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 68 | 68 | 46 | $878 |
| Acyclovir Generic | 68 | 132 | 18 | $577 |
| Prednisone Generic | 64 | 77 | 21 | $199 |
Brand drugs: - claims; generic drugs: 2,459 claims; opioid claims: 295.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter R Ennever $2,260 ($2,260 in general payments such as food, travel and fees) from 28 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,126.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 16 | $1,126 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $226 |
| Pfizer Inc. PFE | 5 | $105 |
| Janssen Biotech, Inc. JNJ | 3 | $72.42 |
| Merck Sharp & Dohme LLC MRK | 3 | $60.58 |
| Exelixis Inc. EXEL | 2 | $52.42 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $51.7 |
| Genzyme Corporation SNY | 2 | $50.88 |
| Sobi, Inc SOBI.ST | 2 | $43.88 |
| Incyte Corporation INCY | 2 | $40.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.